Annexon (ANNX) Shares Outstanding (2019 - 2026)
Annexon (ANNX) posted quarterly Shares Outstanding (Entity) of $162.5 million for Q1 2026, up 9.72% year-over-year from $148.1 million in Q1 2025, and up 8.8% quarter-over-quarter from $149.4 million in Q4 2025.
Annexon (ANNX) Shares Outstanding (2019 - 2026) Analysis & Trends
Annexon's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $162.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 9.72% year-over-year to $162.5 million; the TTM figure through Mar 2026 stood at $162.5 million (up 9.72% YoY), while the FY2025 annual figure was $149.4 million, up 8.7% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $162.5 million, up from $149.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $162.5 million in Q1 2026, with the low at $38.6 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $105.5 million (2024), against an average of $103.5 million.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) gained 0.74% in 2022, then surged 94.88% in 2023.
- Annexon's Shares Outstanding (Entity) stood at $47.7 million in 2022, then soared by 64.22% to $78.4 million in 2023, then soared by 75.33% to $137.4 million in 2024, then grew by 8.7% to $149.4 million in 2025, then increased by 8.8% to $162.5 million in 2026.
- Business Quant data shows ANNX's Shares Outstanding (Entity) at $162.5 million in Q1 2026, $149.4 million in Q4 2025, and $149.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Annexon | 1.00 Bn | 1.00 Bn | - | 201.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 194.20 Mn |
| Mar 31, 2026 | 194.20 Mn |
| Dec 31, 2025 | 155.11 Mn |
| Sep 30, 2025 | 149.12 Mn |
| Jun 30, 2025 | 148.32 Mn |
| Mar 31, 2025 | 148.11 Mn |
| Dec 31, 2024 | 137.40 Mn |
| Sep 30, 2024 | 139.93 Mn |
| Jun 30, 2024 | 130.13 Mn |
| Mar 31, 2024 | 122.67 Mn |
| Dec 31, 2023 | 75.67 Mn |
| Sep 30, 2023 | 75.34 Mn |
| Jun 30, 2023 | 75.23 Mn |
| Mar 31, 2023 | 73.86 Mn |
| Dec 31, 2022 | 54.67 Mn |
| Sep 30, 2022 | 68.65 Mn |
| Jun 30, 2022 | 38.58 Mn |
| Mar 31, 2022 | 38.56 Mn |
| Dec 31, 2021 | 38.32 Mn |
| Sep 30, 2021 | 38.34 Mn |